Homo Evolutis Info archive
Date : April 2012

A new hope

Categories: .General, Bio-tech, Med & Neuro
Tags: No Tags
Published on: April 10, 2012

“Vaxil Biotherapeutics Ltd. announced today positive interim results from its Phase I/II therapeutic cancer vaccine trial in Multiple Myeloma patients. Vaxil is a private clinical stage biopharmaceutical company developing a new class of synthetic T-cell vaccines based on its proprietary VaxHit technology. Vaxil’s lead product ImMucin is an anti-MUC1 therapeutic vaccine and is currently being[…]

Welcome , today is Monday, August 21, 2017